About Me

We are a well rounded group of writers,editors and publishers who love reporting the facts and nothings but the facts.

Thursday, October 14, 2010

A.M. vitals: Novartis to two drugs, scrap-take charge $ 590 million

End of the Line: Novartis takes scrapping a 590 million US dollars to cover the costs of work on two experimental drugs — one an antifungal agent that chronic hepatitis C, the other the WSJ

Read more ...

No comments:

Post a Comment